- Exchange: NASDAQ CM
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Snapshot for Athersys Inc (ATHX)
| Open: | 1.8500 | Day's Range: | 1.8100 - 1.9600 | Volume: | 356,630 |
|---|---|---|---|---|---|
| Previous Close: | 1.9300 | 52wk Range: | 0.9500 - 2.4180 | 1-Yr Rtn: | +32.87% |
Key Statistics for ATHX
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | -0.5000 |
| Est. EPS (USD) (12/2013) | -0.4730 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 104.73 |
| Shares Outstanding (M) | 56.30 |
| 30 Day Average Volume | 1,085,326 |
| Price/Book (mrq) | 7.7802 |
| Price/Sale (ttm) | 10.2777 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/13/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for ATHX
Company Profile & Key Executives for ATHX
Athersys Incorporated is a biotechnology company. The Company has developed technologies that will help identify gene and related proteins and create synthetic human chromosomes.
| Gil Van BokkelenChairman/CEO/Co-Founder | William O Lehmann Jr "BJ"President/COO/Secretary |
| John J HarringtonExec VP/Chief Scientific Ofcr | Robert J DeansExec VP:Regenerative Medicine |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
ATHX News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page